Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1975 2
1976 1
1983 1
1984 1
1986 3
1989 4
1990 4
1991 4
1992 4
1993 8
1994 6
1995 6
1996 6
1997 14
1998 15
1999 15
2000 16
2001 20
2002 14
2003 13
2004 24
2005 23
2006 18
2007 19
2008 26
2009 18
2010 20
2011 21
2012 23
2013 26
2014 15
2015 24
2016 24
2017 30
2018 37
2019 22
2020 24
2021 32
2022 44
2023 40
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

604 results

Results by year

Filters applied: . Clear all
Page 1
Harnessing gastrointestinal organoids for cancer therapy.
Maubach G, Naumann M. Maubach G, et al. Among authors: naumann m. Trends Mol Med. 2024 Apr 13:S1471-4914(24)00065-0. doi: 10.1016/j.molmed.2024.03.010. Online ahead of print. Trends Mol Med. 2024. PMID: 38616435 Free article.
Quantification of Polystyrene Uptake by Different Cell Lines Using Fluorescence Microscopy and Label-Free Visualization of Intracellular Polystyrene Particles by Raman Microspectroscopic Imaging.
Roth A, Tannert A, Ziller N, Eiserloh S, Göhrig B, Guliev RR, Gonzalez Vazquez MJ, Naumann M, Mosig AS, Stengel S, Heutelbeck ARR, Neugebauer U. Roth A, et al. Among authors: naumann m. Cells. 2024 Mar 5;13(5):454. doi: 10.3390/cells13050454. Cells. 2024. PMID: 38474417 Free PMC article.
Prospective study validating a multidimensional treatment decision score predicting the 24-month outcome in untreated patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis, the ProVal-MS study.
Bayas A, Mansmann U, Ön BI, Hoffmann VS, Berthele A, Mühlau M, Kowarik MC, Krumbholz M, Senel M, Steuerwald V, Naumann M, Hartberger J, Kerschensteiner M, Oswald E, Ruschil C, Ziemann U, Tumani H, Vardakas I, Albashiti F, Kramer F, Soto-Rey I, Spengler H, Mayer G, Kestler HA, Kohlbacher O, Hagedorn M, Boeker M, Kuhn K, Buchka S, Kohlmayer F, Kirschke JS, Behrens L, Zimmermann H, Bender B, Sollmann N, Havla J, Hemmer B; ProVal-MS study group. Bayas A, et al. Among authors: naumann m. Neurol Res Pract. 2024 Mar 7;6(1):15. doi: 10.1186/s42466-024-00310-x. Neurol Res Pract. 2024. PMID: 38449051 Free PMC article.
604 results